|
Chronic liver disease
|
0.010 |
Biomarker
|
group |
BEFREE |
All patients and controls completed one generic HRQL questionnaire (MOS SF-36) and one liver-disease specific instrument (Chronic Liver Disease Questionnaire, CLDQ).
|
17406828 |
2007 |
|
Precursor B-cell lymphoblastic leukemia
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
Hereby, samples from precursor B-cell acute lymphoblastic leukemia (ALL) could be distinguished from cases of acute myeloid leukemia by virtue of N33, EGR4, CDC2, CCND2, or MOS hypermethylation in ALL.
|
15538567 |
2005 |
|
Malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
Alterations of chromosomes (3p, 5q, 9p), genes (Rb, C-myc, C-mos, hTERT), proteins (p16, p53, K-ras, hnRNP A2/B1, MCM2, EGFR, erbB-2, erbB-3, erbB-4) and others can be found in lung cancer.
|
15452456 |
2004 |
|
Carcinoma of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
Alterations of chromosomes (3p, 5q, 9p), genes (Rb, C-myc, C-mos, hTERT), proteins (p16, p53, K-ras, hnRNP A2/B1, MCM2, EGFR, erbB-2, erbB-3, erbB-4) and others can be found in lung cancer.
|
15452456 |
2004 |
|
Primary malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
Alterations of chromosomes (3p, 5q, 9p), genes (Rb, C-myc, C-mos, hTERT), proteins (p16, p53, K-ras, hnRNP A2/B1, MCM2, EGFR, erbB-2, erbB-3, erbB-4) and others can be found in lung cancer.
|
15452456 |
2004 |
|
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Alterations of K-ras and c-mos, two pivotal components of this pathway, have been implicated in non-small cell lung carcinogenesis.
|
11778648 |
2001 |
|
Ovarian Teratoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We have analysed the entire coding region of the c-MOS gene in a series of human ovarian teratomas to determine whether there are any cancer-causing alterations.
|
9635841 |
1998 |
|
Pheochromocytoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
|
8695346 |
1996 |
|
Adrenal Gland Pheochromocytoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
|
8695346 |
1996 |
|
Seminoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Higher levels of c-mos expression were observed in several cases of seminomas and embryonal carcinomas.
|
7908857 |
1994 |
|
Embryonal Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Higher levels of c-mos expression were observed in several cases of seminomas and embryonal carcinomas.
|
7908857 |
1994 |
|
Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We generated three human c-mos-specific antisera and report here the detection of c-mos protein in a human neuroblastoma cell line, SK-N-BE2 (BE2).
|
8502488 |
1993 |
|
Central neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We generated three human c-mos-specific antisera and report here the detection of c-mos protein in a human neuroblastoma cell line, SK-N-BE2 (BE2).
|
8502488 |
1993 |
|
Childhood Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
We generated three human c-mos-specific antisera and report here the detection of c-mos protein in a human neuroblastoma cell line, SK-N-BE2 (BE2).
|
8502488 |
1993 |
|
Congenital chromosomal disease
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Structural alterations of the c-mos locus in benign pleomorphic adenomas with chromosome abnormalities of 8q12.
|
1677749 |
1991 |
|
Colorectal Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The frequency of the rare 5 kb c-mos allele was significantly higher than that observed in control groups of patients with colorectal neoplasms or lymphoproliferative disorders.
|
1679639 |
1991 |
|
Lymphoproliferative Disorders
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The frequency of the rare 5 kb c-mos allele was significantly higher than that observed in control groups of patients with colorectal neoplasms or lymphoproliferative disorders.
|
1679639 |
1991 |
|
Down Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Translocation of the MOS gene in a rare t(8;16) associated with acute myeloblastic leukemia and Down syndrome.
|
2522812 |
1989 |
|
Acute lymphocytic leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls.
|
2567285 |
1989 |
|
Acute leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
This is the first report of the transposition of MOS in association with acute leukemia.
|
2522812 |
1989 |
|
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls.
|
2567285 |
1989 |
|
Complete Trisomy 21 Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Translocation of the MOS gene in a rare t(8;16) associated with acute myeloblastic leukemia and Down syndrome.
|
2522812 |
1989 |
|
Thyroid Neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
These findings are the first report of MOS expression in any human tissue, and indicate that MOS oncogene activation might be important in the development of some thyroid tumours.
|
2974318 |
1988 |
|
Neoplasms, Intracranial
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Rare Ha-ras and c-mos alleles in patients with intracranial tumors.
|
3352917 |
1988 |
|
melanoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Human melanocytes infected with Ki-MSV or Ha-MSV, but not amphotropic MuLV, undergo a series of transformation-related changes that are characteristic of malignant melanoma.
|
2430046 |
1986 |